Griffin Asset Management, Inc. Biomea Fusion, Inc. Transaction History
Griffin Asset Management, Inc.
- $799 Million
- Q1 2025
A detailed history of Griffin Asset Management, Inc. transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 51,300 shares of BMEA stock, worth $86,697. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,300
Previous 94,570
45.75%
Holding current value
$86,697
Previous $366,000
70.22%
% of portfolio
0.01%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
125Shares Held
17.4MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.03 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.96 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$2.45 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$2.37 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.35 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $49.5M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...